Tag: Therapy & Procedures: Misc.
ASA: Racial Differences Seen in Treatment of Common Poststroke Sequelae
Black patients significantly less likely than non-Hispanic Whites to receive treatment for arousal, spasticity, mood at 14 days
Momelotinib Yields Clinically Significant Improvement in Myelofibrosis
Significantly greater proportion of patients reported 50 percent or greater reduction in total symptom score with momelotinib versus danazol
Adjuvant Therapy Recommendations for Breast Cancer Drop Between Ages 69 and 70
Year-over-year age difference independent predictor for adjuvant radiation and endocrine therapy recommendations at age 70 versus 69 years
Tumor-Infiltrating Lymphocytes Up PFS in Advanced Melanoma
Significantly longer progression-free survival seen with infusion of tumor-infiltrating lymphocytes versus ipilimumab
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
Immunocompromised patients can still receive convalescent plasma
Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
Metastasis-directed therapy can delay initiation of systemic therapy in patients with solitary oligorecurrent metastatic lesion
Adverse Events Mild, Rare With mAb Treatment for COVID-19 in Pregnancy
No differences seen in any obstetric-associated outcome or in composite 28-day COVID-19 outcome
Higher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
Overall, event-free, relapse-free survival improved in patients receiving higher doses of tisagenlecleucel, with no increased toxicity
Marketing of Shockwave Therapy for Erectile Dysfunction Raises Concerns
Techniques, costs, and provider credentials in biggest U.S. cities vary widely
ACC: Lasting Reduction in BP Seen With Radiofrequency Renal Denervation
Significant reductions in systolic and diastolic BP observed at up to 36 months following intervention versus sham control procedure
